The Renin-Angiotensin-Aldosterone System: Cardiorenal Effects and Implications for Renal and Cardiovascular Disease States
- 1 July 2003
- journal article
- review article
- Published by Elsevier BV in The American Journal of the Medical Sciences
- Vol. 326 (1), 15-24
- https://doi.org/10.1097/00000441-200307000-00003
Abstract
No abstract availableThis publication has 93 references indexed in Scilit:
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureThe New England Journal of Medicine, 2001
- Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study)The American Journal of Cardiology, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureThe New England Journal of Medicine, 1999
- Angiotensin II Activates the Proinflammatory Transcription Factor Nuclear Factor-κB in Human MonocytesBiochemical and Biophysical Research Communications, 1999
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- Angiotensin II Type 2 Receptor Inhibits Cell Proliferation and Activates Tyrosine PhosphataseHypertension, 1996
- Blockade of the Renin-Angiotensin System in Cardiac Pressure-Overload Hypertrophy in RatsHypertension, 1995
- Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.Hypertension, 1990
- Hyperinsulinemia and the aldosterone and pressor responses to angiotensin II.Hypertension, 1990
- Dietary Protein Intake and the Progressive Nature of Kidney Disease:The New England Journal of Medicine, 1982